Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria; Max Perutz Labs, Vienna BioCenter, 1030 Vienna, Austria; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, 1030 Vienna, Austria; University of Vienna, Center for Molecular Biology, Department for Biochemistry and Cell Biology, 1030 Vienna, Austria.
Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria.
Cell. 2023 May 11;186(10):2176-2192.e22. doi: 10.1016/j.cell.2023.04.009. Epub 2023 May 2.
The ClpC1:ClpP1P2 protease is a core component of the proteostasis system in mycobacteria. To improve the efficacy of antitubercular agents targeting the Clp protease, we characterized the mechanism of the antibiotics cyclomarin A and ecumicin. Quantitative proteomics revealed that the antibiotics cause massive proteome imbalances, including upregulation of two unannotated yet conserved stress response factors, ClpC2 and ClpC3. These proteins likely protect the Clp protease from excessive amounts of misfolded proteins or from cyclomarin A, which we show to mimic damaged proteins. To overcome the Clp security system, we developed a BacPROTAC that induces degradation of ClpC1 together with its ClpC2 caretaker. The dual Clp degrader, built from linked cyclomarin A heads, was highly efficient in killing pathogenic Mycobacterium tuberculosis, with >100-fold increased potency over the parent antibiotic. Together, our data reveal Clp scavenger proteins as important proteostasis safeguards and highlight the potential of BacPROTACs as future antibiotics.
ClpC1:ClpP1P2 蛋白酶是分枝杆菌中蛋白质稳态系统的核心组成部分。为了提高针对 Clp 蛋白酶的抗结核药物的疗效,我们对抗生素环马菌素 A 和依古米辛的作用机制进行了研究。定量蛋白质组学揭示,这些抗生素会导致大量的蛋白质组失衡,包括上调两个未注释但保守的应激反应因子 ClpC2 和 ClpC3。这些蛋白质可能会保护 Clp 蛋白酶免受过多的错误折叠蛋白或环马菌素 A 的影响,我们的研究表明环马菌素 A 模拟了受损的蛋白质。为了克服 Clp 安全系统,我们开发了一种 BacPROTAC,它可以诱导 ClpC1 及其 ClpC2 管家蛋白的降解。双 Clp 降解剂由连接的环马菌素 A 头部组成,在杀灭致病性结核分枝杆菌方面非常有效,其效力比亲本抗生素高出 100 多倍。总之,我们的数据揭示了 Clp 吞噬蛋白作为重要的蛋白质稳态保护剂,并强调了 BacPROTAC 作为未来抗生素的潜力。